Tipping the balance from angiogenesis to fibrosis in CKD

Kidney International Supplements

Volumn 4, Issue 1, 2014, Pages 45-52

  Ballermann, Barbara J ^a   Obeidat, Marya ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

angiogenesis; capillary dropout; fibrosis; hypoxia; rarefaction; shear stress

Indexed keywords

ANGIOGENESIS; CAPILLARY; CHRONIC KIDNEY DISEASE; ENDOTHELIUM CELL; HUMAN; HYPOXIA; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; REVIEW; SURVIVAL;

EID: 84908545287     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2014.9     Document Type: Short Survey

References (100)

1. Eddy AA. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994; 5: 1273-1287.
2. Bonventre JV. Can we target tubular damage to prevent renal function decline in diabetes? Semin Nephrol 2012; 32: 452-462.
3. Kaukinen A, Lautenschlager I, Helin H et al. Peritubular capillaries are rarefied in congenital nephrotic syndrome of the Finnish type. Kidney Int 2009; 75: 1099-1108.
4. Sis B. Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection. Hum Immunol 2012; 73: 1218-1225.
5. Schaper W. Collateral circulation: past and present. Basic Res Cardiol 2009; 104: 5-21.
6. Landazuri N, Joseph G, Guldberg RE et al. Growth and regression of vasculature in healthy and diabetic mice after hindlimb ischemia. Am J Physiol Regul Integr Comp Physiol 2012; 303: R48-R56.
7. Dimmeler S, Zeiher AM. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 2000; 87: 434-439.
8. Browning EA, Chatterjee S, Fisher AB. Stop the flow: a paradigm for cell signaling mediated by reactive oxygen species in the pulmonary endothelium. Annu Rev Physiol 2012; 74: 403-424.
9. Wong MG, Suzuki Y, Tanifuji C et al. Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis. J Am Soc Nephrol 2008; 19: 290-297.
10. Wietecha MS, Cerny WL, DiPietro LA. Mechanisms of vessel regression: toward an understanding of the resolution of angiogenesis. Curr Top Microbiol Immunol 2013; 367: 3-32.
11. Johnson A, DiPietro LA. Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J 2013; 27: 3893-3901.
12. Einecke G, Sis B, Reeve J et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
13. Pober JS, Min W, Bradley JR. Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 2009; 4: 71-95.
14. Ohashi R, Shimizu A, Masuda Y et al. Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol 2002; 13: 1795-1805.
15. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006; 116: 288-296.
16. Grgic I, Campanholle G, Bijol V et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 2012; 82: 172-183.
17. Ninichuk V, Anders HJ. Bone marrow-derived progenitor cells and renal fibrosis. Front Biosci 2008; 13: 5163-5173.
18. He J, Xu Y, Koya D et al. Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease. Clin Exp Nephrol 2013; 17: 488-497.
19. Duffield JS, Humphreys BD. Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int 2011; 79: 494-501.
20. Campanholle G, Ligresti G, Gharib SA et al. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol 2013; 304: C591-C603.
21. Matsumoto M, Tanaka T, Yamamoto T et al. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 2004; 15: 1574-1581.
22. Zhang B, Liang X, Shi W et al. Role of impaired peritubular capillary and hypoxia in progressive interstitial fibrosis after 56 subtotal nephrectomy of rats. Nephrology (Carlton) 2005; 10: 351-357.
23. Manotham K, Tanaka T, Matsumoto M et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 2004; 15: 1277-1288.
24. Yuan HT, Li XZ, Pitera JE et al. Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha. Am J Pathol 2003; 163: 2289-2301.
25. Kairaitis LK, Wang Y, Gassmann M et al. HIF-1alpha expression follows microvascular loss in advanced murine adriamycin nephrosis. Am J Physiol Renal Physiol 2005; 288: F198-F206.
26. Kang DH, Anderson S, Kim YG et al. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 2001; 37: 601-611.
27. Namikoshi T, Satoh M, Horike H et al. Implication of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy. Nephron Physiol 2006; 102: p9-16.
28. Rudnicki M, Perco P, Enrich J et al. Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab Invest 2009; 89: 337-346.
29. Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012; 33: 207-214.
30. Nakagawa T, Lan HY, Zhu HJ et al. Differential regulation of VEGF by TGF-beta and hypoxia in rat proximal tubular cells. Am J Physiol Renal Physiol 2004; 287: F658-F664.
31. Kim BS, Chen J, Weinstein T et al. VEGF expression in hypoxia and hyperglycemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures. J Am Soc Nephrol 2002; 13: 2027-2036.
32. Grone HJ, Simon M, Grone EF. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 1995; 177: 259-267.
33. Kang DH, Joly AH, Oh SW et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 2001; 12: 1434-1447.
34. Eddy AA, Neilson EG. Chronic kidney disease progression. J Am Soc Nephrol 2006; 17: 2964-2966.
35. Pertovaara L, Kaipainen A, Mustonen T et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994; 269: 6271-6274.
36. Kitamura S, Maeshima Y, Sugaya T et al. Transforming growth factor-beta 1 induces vascular endothelial growth factor expression in murine proximal tubular epithelial cells. Nephron Exp Nephrol 2003; 95: e79-e86.
37. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000; 58: 2351-2366.
38. Hanna C, Hubchak SC, Liang X et al. Hypoxia-inducible factor-2alpha and TGF-beta signaling interact to promote normoxic glomerular fibrogenesis. Am J Physiol Renal Physiol 2013; 305: F1323-F1331.
39. McMahon S, Charbonneau M, Grandmont S et al. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem 2006; 281: 24171-24181.
40. Sanchez-Elsner T, Botella LM, Velasco B et al. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 2001; 276: 38527-38535.
41. Sanchez-Elsner T, Botella LM, Velasco B et al. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem 2002; 277: 43799-43808.
42. Pardali E, Goumans MJ, ten Dijke P. Signaling by members of the TGFbeta family in vascular morphogenesis and disease. Trends Cell Biol 2010; 20: 556-567.
43. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
44. Ribatti D, Crivellato E. "Sprouting angiogenesis", a reappraisal. Dev Biol 2012; 372: 157-165.
45. Wei H, Bedja D, Koitabashi N et al. Endothelial expression of hypoxiainducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-beta signaling. Proc Natl Acad Sci USA 2012; 109: E841-E850.
46. Jeltsch M, Leppanen VM, Saharinen P et al. Receptor tyrosine kinase-mediated angiogenesis. Cold Spring Harb Perspect Biol 2013; 5: 1-21.
47. Eilken HM, Adams RH. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr Opin Cell Biol 2010; 22: 617-625.
48. Jiang BH, Liu LZ. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 2009; 102: 19-65.
49. Connolly DT, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-1478.
50. Gospodarowicz D, Brown KD, Birdwell CR et al. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J Cell Biol 1978; 77: 774-788.
51. Suri C, Jones PF, Patan S et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171-1180.
52. Jakobsson L, van Meeteren LA. Transforming growth factor beta family members in regulation of vascular function: in the light of vascular conditional knockouts. Exp Cell Res 2013; 319: 1264-1270.
53. Varma S, Lal BK, Zheng R et al. Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction. Am J Physiol Heart Circ Physiol 2005; 289: H1744-H1751.
54. Perry B, Banyard J, McLaughlin ER et al. AKT1 overexpression in endothelial cells leads to the development of cutaneous vascular malformations in vivo. Arch Dermatol 2007; 143: 504-506.
55. Yang ZZ, Tschopp O, Hemmings-Mieszczak M et al. Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 2003; 278: 32124-32131.
56. Sarbassov DD, Guertin DA, Ali SM et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307: 1098-1101.
57. Wick MJ, Dong LQ, Riojas RA et al. Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositidedependent protein kinase-1. J Biol Chem 2000; 275: 40400-40406.
58. Andjelkovic M, Alessi DR, Meier R et al. Role of translocation in the activation and function of protein kinase B. J Biol Chem 1997; 272: 31515-31524.
59. Alessi DR, Andjelkovic M, Caudwell B et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996; 15: 6541-6551.
60. Franke TF, Yang SI, Chan TO et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995; 81: 727-736.
61. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3- kinase/AKT pathway. Proc Natl Acad Sci USA 1999; 96: 4240-4245.
62. Gericke A, Leslie NR, Losche M et al. PtdIns(4,5)P2-mediated cell signaling: emerging principles and PTEN as a paradigm for regulatory mechanism. Adv Exp Med Biol 2013; 991: 85-104.
63. Suzuki A, Hamada K, Sasaki T et al. Role of PTEN/PI3K pathway in endothelial cells. Biochem Soc Trans 2007; 35: 172-176.
64. Hamada K, Sasaki T, Koni PA et al. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 2005; 19: 2054-2065.
65. Hoshino Y, Nishimura K, Sumpio BE. Phosphatase PTEN is inactivated in bovine aortic endothelial cells exposed to cyclic strain. J Cell Biochem 2007; 100: 515-526.
66. Robert B, St John PL, Hyink DP et al. Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts. Am J Physiol 1996; 271: F744-F753.
67. Fierlbeck W, Liu A, Coyle R et al. Endothelial cell apoptosis during glomerular capillary lumen formation in vivo. J Am Soc Nephrol 2003; 14: 1349-1354.
68. Robert B, Zhao X, Abrahamson DR. Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli. Am J Physiol Renal Physiol 2000; 279: F275-F282.
69. Takahashi T, Takahashi K, Gerety S et al. Temporally compartmentalized expression of ephrin-B2 during renal glomerular development. J Am Soc Nephrol 2001; 12: 2673-2682.
70. Dei Cas A, Gnudi L. VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment? Metabolism 2012; 61: 1666-1673.
71. Scruggs BS, Zuo Y, Donnert E et al. Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of sclerosis. Am J Pathol 2011; 178: 1891-1898.
72. Burri PH, Hlushchuk R, Djonov V. Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn 2004; 231: 474-488.
73. Notoya M, Shinosaki T, Kobayashi T et al. Intussusceptive capillary growth is required for glomerular repair in rat Thy-1.1 nephritis. Kidney Int 2003; 63: 1365-1373.
74. Simon M, Gröne HJ, Jö hren O et al. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 1995; 268: F240-F250.
75. Eremina V, Quaggin SE. The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 2004; 13: 9-15.
76. Lammert E, Axnick J. Vascular lumen formation. Cold Spring Harb Perspect Med 2012; 2: a006619.
77. Fehon RG, McClatchey AI, Bretscher A. Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol 2010; 11: 276-287.
78. Strilic B, Kucera T, Eglinger J et al. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 2009; 17: 505-515.
79. Berryman M, Franck Z, Bretscher A. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 1993; 105(Pt 4): 1025-1043.
80. Wang Y, Kaiser MS, Larson JD et al. Moesin1 and Ve-cadherin are required in endothelial cells during in vivo tubulogenesis. Development 2010; 137: 3119-3128.
81. Tung JJ, Hobert O, Berryman M et al. Chloride intracellular channel 4 is involved in endothelial proliferation and morphogenesis in vitro. Angiogenesis 2009; 12: 209-220.
82. Ulmasov B, Bruno J, Gordon N et al. Chloride intracellular channel protein-4 functions in angiogenesis by supporting acidification of vacuoles along the intracellular tubulogenic pathway. Am J Pathol 2009; 174: 1084-1096.
83. Tung JJ, Kitajewski J. Chloride intracellular channel 1 functions in endothelial cell growth and migration. J Angiogenes Res 2010; 2: 23.
84. Chalothorn D, Zhang H, Smith JE et al. Chloride intracellular channel-4 is a determinant of native collateral formation in skeletal muscle and brain. Circ Res 2009; 105: 89-98.
85. Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 2007; 72: 151-156.
86. Kwon O, Hong SM, Sutton TA et al. Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. Am J Physiol Renal Physiol 2008; 295: F351-F359.
87. Lindenmeyer MT, Kretzler M, Boucherot A et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007; 18: 1765-1776.
88. Advani A, Gilbert RE. The endothelium in diabetic nephropathy. Semin Nephrol 2012; 32: 199-207.
89. Chade AR. Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis. Am J Physiol Regul Integr Comp Physiol 2011; 300: R783-R790.
90. Tanaka T, Kato H, Kojima I et al. Hypoxia and expression of hypoxiainducible factor in the aging kidney. J Gerontol A Biol Sci Med Sci 2006; 61: 795-805.
91. Wei W, Popov V, Walocha JA et al. Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: a corrosion cast study. Kidney Int 2006; 70: 1261-1268.
92. Richard S, Gardie B, Couve S et al. Von Hippel-Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol 2013; 23: 26-37.
93. Stout LC, Whorton EB. Pathogenesis of extra efferent vessel development in diabetic glomeruli. Hum Pathol 2007; 38: 1167-1177.
94. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004; 65: 2003-2017.
95. Zent R, Pozzi A. Antiangiogenic therapy in diabetic nephropathy. J Am Soc Nephrol 2006; 17: 325-327.
96. Kim YG, Suga SI, Kang DH et al. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 2000; 58: 2390-2399.
97. Matsubara O, Takemura T. Renal microvasculature in chronic renal failure. Bull Tokyo Med Dent Univ 1975; 22: 193-205.
98. Higgins DF, Kimura K, Bernhardt WM et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810-3820.
99. Orphanides C, Fine LG, Norman JT. Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int 1997; 52: 637-647.
100. Haase VH. Pathophysiological consequences of HIF activation: HIF as a modulator of fibrosis. Ann NY Acad Sci 2009; 1177: 57-65.